Interleukin 2 restores CD3-ζ chain expression but fails to generate tumour-specific lytic activity in Tumour-Infiltrating Lymphocytes derived from human Colorectal Hepatic Metastases

British Journal of Cancer

Volumn 77, Issue 7, 1998, Pages 1072-1081

  Yoong, K F ^a   Adams, D H ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CD3 chain; Colorectal hepatic metastasis; Tumour infiltrating lymphocyte

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 2; TUMOR PROTEIN; B7 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; LUNG TUMOR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR ASSOCIATED LEUKOCYTE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD3; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 0031596755     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.179     Document Type: Article

References (42)

1. Adams DH, Hubscher SG, Fisher NC, Williams A and Robinson M (1996) Expression of E-selectin (CD62E) and E-selectin ligands in human liver inflammation. Hepatology 24: 533-538
2. Adams DH, Yannelli J, Newman W, Rosenberg SA and Shaw S (1997) Adhesion of tumour-infiltrating lymphocytes to endothelium: a functional and phenotypic analysis. Br J Cancer 75: 1421-1431
3. Allison JP, Hurwitz AA and Leach DR (1995) Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr Opin Immunol 7: 682-686
4. Asbun HJ and Hughes KS (1993) Management of recurrent and metastatic colorectal-carcinoma. Surg Clin North Am 73: 145-166
5. Baer HU, Gertsch P, Matthews JB, Schweizer W, Triller J, Zimmermann A, and Blumgart LH (1989) Resectability of large focal liver-lesions. Br J Surg 76: 1042-104
6. Barth RJ, Camp BJ, Martuscello TA, Dain BJ, and Memoli VA (1996) The cytokine microenvironment of human colon-carcinoma -lymphocyte expression of tumor-necrosis-factor-alpha and interleukin-4 predicts improved survival. Cancer 78: 1168-1178
7. Bateman WJ, Donnellan I, Fraser IA, Wong LS and Morris AG (1995) Lymphocytes infiltrating colorectal-cancer have low proliferative capacity but can secrete normal levels of interferon-gamma. Cancer Immunol Immunother 41: 61-67
8. Boussiotis VA, Gribben JG, Freeman GJ and Nadler LM (1994) Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr Opin Immunol 6: 797-807
9. Burno DK, Kyprianou N, Sartor WM, Fabian DF, Turner J, Vu T, Patel A, Trimbach C and Lefor AT (1995) Transfection of a murine fibrosarcoma with intercellular-adhesion molecule-1 enhances the response to adoptive immunotherapy. Surgery 118: 237-244
10. Burno DK, Fabian DF and Lefor AT (1996) ICAM-1 increases in-vitro adhesion and cytotoxicity in a murine fibrosarcoma. J Surg Res 60: 398-402
11. Camp BJ, Dyhrman ST, Memoli VA, Mott LA and Barth RJ (1996) In-situ cytokine production by breast-cancer tumour-infiltrating lymphocytes. Ann Surg Oncol 3: 176-184
12. Campana D, Coustan-Smith E and Janossy G (1988) Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells. J Immunol Method 107: 79-88
13. Cavallo F, Martinfontecha A, Bellone M, Heltai S, Gatti E, Tornaghi P, Freschi M, Forni G, Dellabona P and Casorati G (1995) Coexpression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur J Immunol 15: 1154-1162
14. Chambers CA and Allison JP (1997) Co-stimulation in T cell responses. Curr Opin Immunol 9: 396-104
15. Coventry BJ, Weeks SC, Heckford SE, Sykes PJ, Bradley J and Skinner JM (1996) Lack of il-2 cytokine expression despite il-2 messenger-rna transcription in tumor-infiltrating lymphocytes in primary human breast-carcinoma - selective expression of early activation markers. J Immunol 156: 3486-3492
16. Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, Oshea JJ, Kudoh S, Klein E, Bukowaski RM and Ochoa AC (1993) Loss of T-cell receptor zeta-chain and p56(lck) in T-cells infiltrating human renal-cell carcinoma. Cancer Res 53: 5613-5616
17. Hughes KS (1988) Resection of the liver for colorectal-carcinoma metastases - a multi-institutional study of indications for resection. Surgery 103: 278-288
18. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T and Rosenberg SA (1994) Identification of a human-melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in-vivo tumor rejection. Proc Natl Acad Sci USA 91: 6458-6462
19. Kronke M, Leonard WJ, Depper JM and Greene WC (1985) Sequential expression of genes involved in human T lymphocyte grow th and differentiation. J Exp Med 161: 1593-1598
20. Kudoh S, Stanley J, Edinger MG, Tubbs RR, Klein E, Bukowski RM and Finke JH (1994) T-lymphocytes infiltrating renal-cell carcinoma have a reduced expression of transferrin receptor. Int J Cancer 58: 369-375
21. Lanier LL and Phillips JH (1996) Inhibitory MHC class I receptors on NK cells and T-cells. Immunol Today 17: 86-91
22. Maeurer MJ, Martin DM, Castelli C, Elder E, Leder G, Storkus WJ and Lotze MT (1995) Host immune-response in renal-cell cancer - interleukin-4 (IL-4) and IL-10 messenger-RNA are frequently defected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol Immunother 41: 111-121
23. Miescher S, Whiteside TL, Carrel S and Vonfliedner V (1986) Functional properties of tumor-infiltrating and blood-lymphocytes in patients with solid tumors - effects of tumor-cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136: 1899-1907
24. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L and Vonfliedner V (1988) Proliferative and cytolytic potentials of purified human tumor-infiltrating lymphocytes - impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer 42: 659-666
25. Mizoguchi H, Oshea JJ, Longo DL, Loeffler CM, McVicar DW and Ochoa AC (1992) Alterations in signal transduction molecules in lymphocytes from tumor-bearing mice. Science 258: 1795-1798
26. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin JL, Vivier E, Anderson P and Kiessling R (1993) Decreased expression of the signal-transducing zeta-chains in tumor-infiltrating T-cells and NK cells of patients with colorectal-carcinoma. Cancer Res 53: 5610-5612
27. Nakagomi H, Pisa P, Pisa EK, Yamamoto Y, Halapi E, Backlin K, Juhlin C, and Kiessling R (1995) Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 messenger RNA in human renal-cell carcinoma. Int J Cancer 63: 366-371
28. O'Connell J, O'Sullivan GC, Collins JK and Shanahan F (1996) The fas counterattack - fas-mediated T-cell killing by colon-cancer cells expressing fas ligand. J Exp Med 184: 1075-1082
29. Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E and Rosenberg SA (1995) Induction of tumor-reactive CTL from peripheral-blood and tumor-infiltrating lymphocytes of melanoma patients by in-vitro stimulation with an immunodominant peptide of the human-melanoma antigen mart-1. J Immunol 154: 2257-2265
30. Robbins PF and Kawakami Y (1996) Human tumor antigens recognised by T cells. Curr Opin Immunol 8: 628-636
31. Robey E and Allison JP (1995) T-cell activation - integration of signals from the antigen receptor and costimulatory molecules. Immunol Today 16: 306-310
32. Rosenberg SA, Yannelli JR, Yang JC, Topalian SL, Schwanzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JN and White DE (1994) Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin-2. J Natl Cancer Inst 86: 1159-1166
33. Sanderson CJ (1976) The uptake and retention of chromium by cells. Transplantation 21: 526-529
34. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS and Turka LA (1995) CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 but spares Th2 cytokines. J Exp Med 181: 1869-1874
35. Schendel DJ, Gansbacher B, Oberneder R, Kriegmair M, Hofstetter A, Riethmuller G and Segurado OG (1993) Tumor-specific lysis of human renal-cell carcinomas by tumor-infiltrating lymphocytes. 1. HLA A2-restricted recognition of autologous and allogeneic-tumor lines. J Immunol 151: 4209-4220
36. Schwartz RH (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068
37. Shimizu Y, Iwatsuki S, Herberman RB and Whiteside TL (1990) Clonal analysis of tumour infiltrating lymphocytes from human primary and metastatic liver tumours. Int J Cancer 46: 878-883
38. Townsend SE and Allison JP (1993) Tumor rejection after direct costimulation of CD8 + T-cells by B7-transfected melanoma-cells. Science 259: 368-370
39. Townsend SE, Su FW, Atherton JM and Allison JP (1994) Specificity and longevity of antitumor immune-responses induced by B7-transfected tumors. Cancer Res 54: 6477-6483
40. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, van den Eynde B, Knuth A and Boon T (1991) A gene encoding an antigen recognised by cytolytic T lymphocytes on a human melanoma. Science 2: 1643-1647
41. Yannelli JR (1991) The preparation of effector cells for use in the adoptive cellular therapy of cancer. J Immunol Method 139: 1-16
42. Yoong KF and Adams DH (1996) Tumour infiltrating lymphocytes: insights into tumour immunology and potential for immunotherapy. J Clin Mol Pathol 49: M267-M277